Register for OBR daily


GH_edutorial_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CNDO $3.30 0.5100 +18.28%
AEZS $0.79 0.0649 +8.89%
CLDX $28.66 2.2900 +8.68%
BLRX $2.80 0.2100 +8.11%
GALE $1.98 0.1300 +7.03%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ONCY $1.04 -0.1199 -10.34%
GTXI $0.76 -0.0400 -5.00%
MEIP $5.48 -0.2600 -4.53%
GERN $2.83 -0.1300 -4.39%
MNKD $5.96 -0.2000 -3.25%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

Genmab Enters Commercial DuoBody Technology Agreement With BioNovion in the Field of Immuno-Oncology

(Benzinga) Feb 19, 2015 - Genmab A/S announced today it has entered a co-development and commercialization agreement with BioNovion to evaluate a number of DuoBody product candidates targeting immune checkpoints.
read article 



CMS Oncology Care Model Names NCCN Guidelines as High-Quality Care and Evidence-Based Recommendations

(NCCN) Feb 18, 2015 - Centers for Medicare & Medicaid Services encourages concordance to NCCN Guidelines for Medicare patients in order to achieve better care, smarter spending, and healthier people.
read press release 



Apotex Announces FDA Has Accepted For Filing Its Biosimilar Application For Filgrastim (Grastofil™)

(Apotex) Feb 17, 2015 - Apotex Inc., a rising competitor in the global biosimilars market, announced today that, as of February 13th, 2015, the US Food and Drug Administration has accepted for filing the company's application for Filgrastim [Grastofil™], a biosimilar version of Amgen's Neupogen®. This product has been jointly developed with Intas Pharmaceuticals Ltd.
read corporate press release 



FDA Broadens Revlimid's Approved Use to Include Newly Diagnosed Multiple Myeloma

(The Myeloma Beacon) Feb 18, 2015 - The U.S. Food and Drug Administration (FDA) has ex­panded the of­ficial­ly ap­proved use of Revlimid to include the treat­ment of newly diag­nosed multiple myeloma.
read article 



Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of MM-121 in Patients With Heregulin Positive Non-Small Cell Lung Cancer

(MarketWatch) Feb 19, 2015 - Merrimack Pharmaceuticals, Inc. today announced the initiation of a global, open-label, biomarker-selected, randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with docetaxel or pemetrexed versus docetaxel or pemetrexed alone in patients with heregulin positive, locally advanced or metastatic non-small cell lung cancer.
read article 



Looking For That Fruit or Vegetable That Might Prevent Cancer?

(Washington Post) Feb 16, 2015 - Only about half of the recommendations on two internationally syndicated TV medical talk shows were supported by scientific evidence, according to a recent study in the journal BMJ.
read article (free registration required) 



Chemical Used to Color Sodas Linked to Cancer Risk

(PBS Newshour/The Rundown blog) Feb 19, 2015 - The brown coloring in your soda may be linked to increased cancer risk, according to a new study.
read article 



New Insight Into a Fragile Protein Linked to Cancer and Autism

(American Chemical Society) Feb 18, 2015 - In recent years, scientists have found a surprising connection between some people with autism and certain cancer patients: They have mutations in the same gene, one that codes for a protein critical for normal cellular health.
read press release 



Biomarker Discovery Offers Clearer Prognosis For Bowel and Rectal Cancer Patients

(Macquarie University [Sydney, Australia]) Feb 19, 2015 - For the first time, a biomarker discovered by Macquarie University and Concord Repatriation General Hospital researchers will allow clinicians to distinguish certain types of colorectal cancer patients who do relatively well after surgery from those who may subsequently die from their disease.
read press release 



Breast Cancer Spread May Be Tied to Cells That Regulate Blood Flow

(MD Anderson) Feb 19, 2015 - Tumors require blood to emerge and spread. That is why scientists at The University of Texas MD Anderson Cancer Center believe that targeting blood vessel cells known as pericytes may offer a potential new therapeutic approach when combined with vascular growth factors responsible for cell death.
read press release 



Roche Gets FDA Priority Review for Cancer Treatment

(Morningstar/Dow Jones Newswires) Feb 19, 2015 - Roche Holding AG said Thursday one of its skin cancer treatments had been granted a priority review by the U.S. Food and Drug Administration, cutting the time the drug might take to become available to patients.
read article 



Breast Cancer Cocktail Buys More Than a Year of Life

(NBCNews.com) Feb 19, 2015 – A cocktail of three breast cancer drugs buys patients an extra 16 months of life — a good news story so unusual, doctors have rushed to make it standard therapy, researchers said Wednesday.
read article 



Vaccine That Targets 9 Strains of HPV Boosts Cancer Protection, Study Says

(Los Angeles Times/Science Now) Feb 18, 2015 - When it comes to HPV vaccines, more protection is better.
read article (free registration required) 



Doctors Strive to Do Less Harm by Inattentive Care

(New York Times) Feb 17, 2015 - Inattentive medical care is now seen as a real harm. To remedy the situation, many hospitals and doctors are surveying those in their care.
read article 



After Lobbying Push, Drugmaker Resubmits Women's Sex Pill

(FoxNews.com/Associated Press) Feb 17, 2015 - The makers of a twice-rejected pill designed to boost female libido are resubmitting their drug to federal health regulators, following a recent lobbying blitz by politicians, women's groups and consumer advocates aimed at pushing it onto the market.
read article 



FDA to Hold a Hearing on Allowing Generic Drug Makers to Update Labels

(Wall Street Journal/Pharmalot blog) Feb 18, 2015 - A rule that the FDA has proposed to update generic drug labeling will be debated at a full-day hearing next month, underscoring the extent to which the proposal has become controversial.
read article (paid subscription required) 



NHS Misses Urgent Cancer Therapy Targets for Whole Year

(BBC News) Feb 18, 2015 - The NHS in England has missed a key cancer target for the whole of 2014, official figures show. At least 85% of patients should start treatment within 62 days of being referred by GPs.
read article 



A Cancer Cluster Is Tough to Prove

(New York Times) Feb 16, 2015 - Last month, thousands of Marines and their families were blocked in federal court from pursuing their claim that the government had given them cancer.
read article 



Cancer Documentary Project Draws Widespread Support

(Medpage Today) Feb 17, 2015 - Three-part "Cancer: Emperor of All Maladies" documentary to debut in late March.
read article (free registration required) 



NYU Langone Medical Center and the Technion-Israel Institute of Technology to Forge Groundbreaking Partnership in Cancer Research

(NYU Langone) Feb 18, 2015 - Two of the world’s preeminent academic and research institutions -- NYU Langone Medical Center and the Technion-Israel Institute of Technology -- formally announced a $9 million gift from philanthropists Laura and Isaac Perlmutter that will fund two major, joint research endeavors with potentially far-reaching impact in advancing cancer research.
read press release 



MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

(MD Anderson) Feb 18, 2015 - The alliance will promote behavior that will lower children’s lifelong risk of developing cancer.
read press release 



MD Anderson President Named as Fellow of Top Cancer Research Group

(MD Anderson) Feb 18, 2015 - Ron DePinho will be inducted as a new fellow of the American Association for Cancer Research Academy.
read press release 



PCMH Model Narrowed Economic Gap for Cancer Screening

(Medscape Medical News) Feb 18, 2015 - Patient-centered medical homes (PCMHs) may raise cancer screening rates, especially among groups of lower socioeconomic status, researchers have found.
read article (free registration required) 



Association of Community Cancer Centers Commends New Oncology Care Model as a Step in the Right Direction

(ACCC) Feb 18, 2015 - Last week the Center for Medicare and Medicaid Innovation (CMMI) at the Centers for Medicare & Medicaid Services (CMS) announced its much-anticipated Oncology Care Model (OCM), a new voluntary program for physician–led practices to test the bundling of payments for chemotherapy administration. The OCM is the second specialty care model to be announced at CMMI, and the first in oncology care.
read press release 



OncoSec Medical Inc. and Heat Biologics, Inc. Announce Collaboration to Evaluate Combination of Immunotherapy Platforms

(MarketWatch) Feb 18, 2015 - OncoSec Medical Inc., a company developing DNA-based intratumoral cancer immunotherapies, and Heat Biologics, Inc., a clinical stage biopharmaceutical company focused on the development of cancer immunotherapies, today announced that they have entered into an agreement to evaluate the combination of the immunotherapy approaches developed by each company.
read article